BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/30/2019 2:14:06 AM | Browse: 1191 | Download: 2586
 |
Received |
|
2019-07-24 08:52 |
|
Peer-Review Started |
|
2019-07-24 08:52 |
|
First Decision by Editorial Office Director |
|
2019-08-18 00:01 |
|
Return for Revision |
|
2019-08-23 01:14 |
|
Revised |
|
2019-09-08 14:06 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2019-09-10 10:57 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2019-09-10 21:00 |
|
Articles in Press |
|
2019-09-10 21:00 |
|
Edit the Manuscript by Language Editor |
|
2019-09-16 23:30 |
|
Typeset the Manuscript |
|
2019-09-27 11:15 |
|
Publish the Manuscript Online |
|
2019-09-30 02:14 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Control Study |
| Article Title |
Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wen-Tao Wang, Chang-Qing Guo, Guang-Hui Cui and Song Zhao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Song Zhao, MD, Doctor, Doctor, Department of Thoracic Surgery, First Affiliated Hospital of Zhengzhou University, 12th floor, Building 6, Zhengzhou University first affiliated Hospital, No. 1 Longhu Middle Ring Road, Jinshui District, Zhengzhou City, Henan Province, Zhengzhou 450000, Henan Province, China. zhaosong1212@qq.com |
| Key Words |
miR-21; miR-93; Esophageal squamous cell carcinoma; Radiotherapy and chemotherapy; Prognosis; Diagnosis |
| Core Tip |
In order to observe the roles of miR-21 and miR-93 in radiotherapy and chemotherapy efficacy and prognosis on esophageal squamous cell carcinoma (ESCC), real time Quantitative polymerase chain reaction was adopted to determine the expressions of plasma miR-21 and miR-93 in ESCC patients. Multivariate Logistic regression analysis revealed that patients with high T stage and M stage and high expressions of miR-21(> 5.80) and miR-93 (> 4.71) suffered increased risks of ineffective radiotherapy and chemotherapy, and multivariate Cox regression analysis revealed that patients with high T stage, N stage, and M stage, and high expressions of miR-21 (> 5.60), and miR-93 (> 3.87) suffered increased risk of death in 3 years. |
| Publish Date |
2019-09-30 02:14 |
| Citation |
Wang WT, Guo CQ, Cui GH, Zhao S. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma. World J Gastroenterol 2019; 25(37): 5604-5618
|
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i37/5604.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i37.5604 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
